Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
Log In
Resverlogix's Lead Drug Featured in Key Scientific Publication
Have an interest in this Story?
Sign Up for Real-Time email updates
KOTA Territory News
|
July 18, 2008
RVX-208 is the only Apo-Al/HDL drug to be highlighted TSX Exchange Symbol: RVX CALGARY, July 18 /PRNewswire-FirstCall/ - Resverlogix Corp. ('Resverlogix' or the 'Company') is pleased to announce that Resverlogix's lead drug is featured prominently in an article titled 'Emerging Antidyslipidemic Drug...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Putin: US orchestrated conflict in Georgia
- Washington Times
Gulf Coast businesses say they're prepared for new storms
- Creston News Advertiser
Death toll climbs as Gustav barrels through Caribbean
- Keep Media
Georgia, Moscow to Cut Diplomatic Ties
- Time
Earthquake hits off British Columbia coast
- KUTV
Featured Members
Alexandr Migunov
Consultant
Real Estate Industry
Jaime Neyra Morales
Relationship Manager, Commercial Banking
Banking
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2008 Congoo.com. All Rights Reserved.